Magnetar Financial LLC Adma Biologics, Inc. Transaction History

Magnetar Financial LLC

$3.89 Billion
Q2 2024

A detailed history of Magnetar Financial LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Magnetar Financial LLC holds 3,712,258 shares of ADMA stock, worth $72 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares

3,712,258

Previous 4,659,378 20.33%

Holding current value

$72 Million

Previous $30.8 Million 34.96%

% of portfolio

1.07%

Previous 0.82%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.98 - $11.18 $5.66 Million - $10.6 Million	-947,120 Reduced 20.33%	3,712,258 $41.5 Million
Q1 2024 May 15, 2024	SELL	$4.4 - $6.74 $7.14 Million - $10.9 Million	-1,623,178 Reduced 25.84%	4,659,378 $30.8 Million
Q4 2023 Feb 13, 2024	BUY	$3.08 - $4.52 $1.26 Million - $1.85 Million	408,378 Added 6.95%	6,282,556 $28.4 Million
Q3 2023 Nov 14, 2023	SELL	$3.47 - $4.61 $559,919 - $743,869	-161,360 Reduced 2.67%	5,874,178 $21 Million
Q2 2023 Aug 11, 2023	SELL	$3.12 - $4.22 $3.24 Million - $4.39 Million	-1,039,184 Reduced 14.69%	6,035,538 $22.3 Million
Q1 2023 May 15, 2023	BUY	$3.01 - $3.87 $2.67 Million - $3.43 Million	887,406 Added 14.34%	7,074,722 $23.4 Million
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $4.49 Million - $7.05 Million	1,815,908 Added 41.54%	6,187,316 $24 Million
Q3 2022 Nov 14, 2022	SELL	$2.03 - $2.86 $5.05 Million - $7.12 Million	-2,489,464 Reduced 36.28%	4,371,408 $10.6 Million
Q2 2022 Aug 15, 2022	BUY	$1.43 - $2.2 $503,295 - $774,301	351,955 Added 5.41%	6,860,872 $13.6 Million
Q1 2022 May 16, 2022	SELL	$1.28 - $1.83 $801,319 - $1.15 Million	-626,031 Reduced 8.77%	6,508,917 $11.9 Million
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $6.89 Million - $10.5 Million	6,323,986 Added 779.81%	7,134,948 $10.1 Million
Q3 2021 Nov 12, 2021	BUY	$1.13 - $1.65 $231,459 - $337,971	204,831 Added 33.79%	810,962 $916,000
Q2 2021 Aug 06, 2021	SELL	$1.51 - $2.07 $17,804 - $24,407	-11,791 Reduced 1.91%	606,131 $970,000
Q1 2021 May 14, 2021	BUY	$1.67 - $2.95 $97,544 - $172,309	58,410 Added 10.44%	617,922 $1.09 Million
Q4 2020 Feb 12, 2021	BUY	$1.8 - $2.56 $359,155 - $510,799	199,531 Added 55.43%	559,512 $1.09 Million
Q3 2020 Nov 16, 2020	BUY	$2.04 - $3.74 $445,654 - $817,032	218,458 Added 154.36%	359,981 $860,000
Q2 2020 Aug 14, 2020	SELL	$2.42 - $3.29 $606,694 - $824,803	-250,700 Reduced 63.92%	141,523 $415,000
Q1 2020 May 15, 2020	BUY	$1.5 - $4.59 $480,000 - $1.47 Million	320,000 Added 443.07%	392,223 $1.13 Million
Q4 2019 Feb 13, 2020	BUY	$3.89 - $5.15 $86,447 - $114,448	22,223 Added 44.45%	72,223 $289,000
Q3 2019 Nov 14, 2019	BUY	$3.19 - $5.39 $159,500 - $269,500	50,000 New	50,000 $223,000

Others Institutions Holding ADMA

# of Institutions

265

Shares Held

178M

Call Options Held

535K

Put Options Held

21.2K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.81B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.

Account

Magnetar Financial LLC Adma Biologics, Inc. Transaction History